Meet our experts : Dr. Beat Stoll



Director of GLOSYA Medical

A physician specialising in internal medicine and public health, with a private doctorate from the University of Geneva, Dr Stoll is involved in global health training and research at the international level, notably for the University of Geneva, the EssentialMed Foundation, WHO, the ICRC and the Faculty of Medicine in Yaoundé, Cameroon, as well as other African institutions and governments.

“You have a sacred fire!” The remark made by his chief doctor and thesis director, the private tutor Dr Jean-Pierre Berger of the Riviera Hospital (formerly the Samaritan) in Vevey, could not be more relevant to the personal commitment of Dr Beat Stoll, director of Glosya Medical.

Indeed, medicine is more than a vocation for this doctor-entrepreneur. This led him very early on to regional hospitals in Switzerland where he learned the foundation stones of internal medicine.

Trained in tropical medicine in Basel, Dr Beat Stoll met his “third great boss”, Professor Dr Tanner, the charismatic director of the Swiss TPH, tropical disease researcher, and renowned health expert in tropical countries. His extraordinary pedagogical approach and his openness to socio-demographic and economic aspects encouraged in Dr Stoll a passion for health in tropical countries and a real fascination for the biology of parasitic cycles. 

Once he arrived in Cameroon, hired by the NGO SolidarMed and the Twinning Foundation of Vevey Hospital, and once he had acclimatised to the initial differences, he quickly became convinced that field medicine requires a global approach. In Africa, the practice of medicine cannot ignore the history, culture, traditions and means of the patient. Only a systemic and contextualised understanding, focused on the patient’s possibilities, can produce the expected results.

In this way, Dr Beat Stoll intends to put his creativity, ingenuity and openness to interdisciplinarity at the service of global medicine.

The freedom to act, to negotiate, to create added value outside the usual framework, to train staff and to develop management in organisations have proven motivating factors that have been constantly reinforced over the years.

Aware of the limited rationality of each individual, he relies on the potential of his projects by focusing on the development of related approaches between traditional and academic medicine. Both in his teaching in public health (MAS in Public Health, University of Geneva), in global health (Master of Science in Global Health, University of Geneva) and in his role as a research expert, he creates the space and dynamics necessary for the contribution of each key player (doctors, engineers, sociologists, economists, politicians, lawyers, etc.) to effectively meet the challenges of global health. 

To improve performance and relevance, he and his organisation aim to compare approaches and draw on multidisciplinary knowledge. Together, professionals develop coherent responses that are adapted to the community health problems of developing countries.

To raise awareness among his audience on how to “motivate communities to consult”, Dr Beat Stoll did not hesitate to start riffing “TB or not TB” on the bass clarinet, along with two fellow musicians from Zimbabwe, at the interdepartmental conference in Moscow in November 2017 on TB issues. His performance left its mark on people’s minds and opened doors for him. 

“Today we know the medical procedures that save lives; the morbidity and mortality observed in Africa are not just a medical problem,” says Dr. Beat Stoll, who describes himself as a committed scientist in the field, placing the patient at the centre of his motivations. He defines program success as an action that “reaches as many people as possible” and potentially “new patients”.

“Success in health is not just a medical act,” he says. Thus the medical action is to health what the instrument solo is to music, an essential part of a more global reality. If the solo honours an instrument, the chorus conveys a message and the music tells a story and makes a lasting impression.

Among Glosya Medical’s many projects today is support for the deployment of GlobalDiagnotiX in Africa. Medical imaging (radiology and ultrasound) is essential to make good local medicine in developing countries and thus contribute to universal health coverage, a priority for WHO action. 

For example, “the place of chest radiography in the tuberculosis diagnosis process is of major importance”. Once implemented, this new radiography device, the result of a real technological change, will meet the many challenges of primary care, including in bush hospitals.

For the Director of Glosya Medical, successes in the field of health are like those in culture, literature, architecture or music: they go through time and leave a legacy for future generations.

Editing: Caroline Haldemann

Sterilux : from innovation to successful business

Sterilux : from innovation to successful business

Sterilux is a young and promising medtech startup. They approached Glosya as one of their objectives is to penetrate the African sterilization market with the affordable Sterox concept they developed in Switzerland.

The initial step was to understand Sterilux Business Plan with the Sterilux CEO, his motivation and needs.

This phase requires to be done thoroughly with on-sites visits for the collection, analysis and preparation of key documentation.

Then it allows Glosya to be able to validate the business plan and clearly articulate the business opportunity for the second step i.e the connection with the Glosya Financial Network in Africa and Switzerland for funding.

In parallel the Glosya team is also working with Sterilux to prepare the deployment phase in Africa.

We look at this third step as the “added value ” phase where all the facets of the market entry in Africa will be discussed and implemented between Sterilux and the Glosya Operational Network in Africa and Switzerland.


For more information on Sterilux click here.

Writing : Patrick Ferronato
Photo: Sterilux

Healthcare Tech in Mauritius: A booming market for Swiss companies

Healthcare Tech in Mauritius: A booming market for Swiss companies

Mauritius has become one of the fastest advancing destinations in the fields of Medical Technology and Treatment in Africa.

While the official mandate for all African countries remains to start or increase manufacturing their own medical equipment, the reality today still sees rapidly growing imports from outside Africa in order to meet existing and up-coming demands and therefore presents a variety of business opportunities for Swiss companies.

Core Market Segments

The healthcare sector in Mauritius has metamorphosed itself into an integrated cluster underpinned by a core group of high-value activities such as Medical Devices, Medical Tourism, Tele Medicine, Alternative Medicine and Wellness.

A variety of global healthcare companies – among them Swiss companies like Novartis and Labatech-Pharma – have already either invested in multi-specialty and super-specialty centres of excellence to cater for the growing healthcare needs or export their products to Mauritius.

Read the full article here.


Source of the article: Switzerland Global Enterprise
Photo credit: ©Pixabay